Pharmac, the agency that decides which medicines are funded in New Zealand, today said it was looking to widen access to four products as part of the first public consultation following its receipt of an additional NZD$604m ($369m) over four years from the government to fund or widen access to more medicines.
Meanwhile, the government is pressing on with efforts to repeal the landmark Therapeutic Products Act (TPA) that was passed by its predecessor last year, and stakeholders have been given until 29 July to comment on a